Vimarsana
Biggest News Aggregation in the World

Page 2 - Marka Kay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marka Kay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marka Kay Today - Breaking & Trending Today

Logicbio Therapeutics (LOGC) Gets a Buy Rating from Chardan Capital - Vimarsana News

Logicbio Therapeutics (LOGC) Gets a Buy Rating from Chardan Capital

Markets In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Logicbio Therapeutics (LOGC – Research Report), with a price target of $20.00. The company’s shares closed last Tuesday at $6.10. According to TipRanks.com, Livshits is a top 100 analyst with an average return of 78.0% and a 71.0% success rate. Livshits covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Crispr Therapeutics AG, and Intellia Therapeutics. Logicbio Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $17.00. Logi...

Source: markets.co